Literature DB >> 22080833

Abnormal nuclear envelopes in the striatum and motor deficits in DYT11 myoclonus-dystonia mouse models.

Fumiaki Yokoi1, Mai T Dang, Tong Zhou, Yuqing Li.   

Abstract

DYT11 myoclonus-dystonia (M-D) is a movement disorder characterized by myoclonic jerks with dystonic symptoms and caused by mutations in paternally expressed SGCE, which codes for ε-sarcoglycan. Paternally inherited Sgce heterozygous knock-out (KO) mice exhibit motor deficits and spontaneous myoclonus. Abnormal nuclear envelopes have been reported in cellular and mouse models of early-onset DYT1 generalized torsion dystonia; however, the relationship between the abnormal nuclear envelopes and motor symptoms are not clear. Furthermore, it is not known whether abnormal nuclear envelope exists in non-DYT1 dystonia. In the present study, abnormal nuclear envelopes in the striatal medium spiny neurons (MSNs) were found in Sgce KO mice. To analyze whether the loss of ε-sarcoglycan in the striatum alone causes abnormal nuclear envelopes, motor deficits or myoclonus, we produced paternally inherited striatum-specific Sgce conditional KO (Sgce sKO) mice and analyzed their phenotypes. Sgce sKO mice exhibited motor deficits in both beam-walking and accelerated rotarod tests, while they did not exhibit abnormal nuclear envelopes, alteration in locomotion, or myoclonus. The results suggest that the loss of ε-sarcoglycan in the striatum contributes to motor deficits, while it alone does not produce abnormal nuclear envelopes or myoclonus. Development of therapies targeting the striatum to compensate for the loss of ε-sarcoglycan function may rescue the motor deficits in DYT11 M-D patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22080833      PMCID: PMC3263984          DOI: 10.1093/hmg/ddr528

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  63 in total

1.  Cadherin-like domains in alpha-dystroglycan, alpha/epsilon-sarcoglycan and yeast and bacterial proteins.

Authors:  Nicholas J Dickens; Scott Beatson; Chris P Ponting
Journal:  Curr Biol       Date:  2002-03-19       Impact factor: 10.834

2.  Refinement of the DYT15 locus in myoclonus dystonia.

Authors:  Fabin Han; Lemuel Racacho; Anthony E Lang; Dennis E Bulman; David A Grimes
Journal:  Mov Disord       Date:  2007-04-30       Impact factor: 10.338

3.  Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome.

Authors:  A Zimprich; M Grabowski; F Asmus; M Naumann; D Berg; M Bertram; K Scheidtmann; P Kern; J Winkelmann; B Müller-Myhsok; L Riedel; M Bauer; T Müller; M Castro; T Meitinger; T M Strom; T Gasser
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

Review 4.  The pathophysiological basis of dystonias.

Authors:  Xandra O Breakefield; Anne J Blood; Yuqing Li; Mark Hallett; Phyllis I Hanson; David G Standaert
Journal:  Nat Rev Neurosci       Date:  2008-03       Impact factor: 34.870

5.  Motor deficits and hyperactivity in cerebral cortex-specific Dyt1 conditional knockout mice.

Authors:  Fumiaki Yokoi; Mai Tu Dang; Shinichi Mitsui; Jianyong Li; Yuqing Li
Journal:  J Biochem       Date:  2007-10-23       Impact factor: 3.387

6.  Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations.

Authors:  E Roze; E Apartis; F Clot; N Dorison; S Thobois; L Guyant-Marechal; C Tranchant; P Damier; D Doummar; N Bahi-Buisson; N André-Obadia; D Maltete; A Echaniz-Laguna; Y Pereon; Y Beaugendre; S Dupont; T De Greslan; C P Jedynak; G Ponsot; J C Dussaule; A Brice; A Dürr; M Vidailhet
Journal:  Neurology       Date:  2008-03-25       Impact factor: 9.910

7.  DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA.

Authors:  Sarah Camargos; Sonja Scholz; Javier Simón-Sánchez; Coro Paisán-Ruiz; Patrick Lewis; Dena Hernandez; Jinhui Ding; J Raphael Gibbs; Mark R Cookson; Jose Bras; Rita Guerreiro; Catarina Resende Oliveira; Andrew Lees; John Hardy; Francisco Cardoso; Andrew B Singleton
Journal:  Lancet Neurol       Date:  2008-02-01       Impact factor: 44.182

8.  Cortical excitability in DYT-11 positive myoclonus dystonia.

Authors:  Emmanuel Roze; Emmanuelle Apartis; Jean-Marc Trocello
Journal:  Mov Disord       Date:  2008-04-15       Impact factor: 10.338

9.  Overexpression of human wildtype torsinA and human DeltaGAG torsinA in a transgenic mouse model causes phenotypic abnormalities.

Authors:  K Grundmann; B Reischmann; G Vanhoutte; J Hübener; P Teismann; T-K Hauser; M Bonin; J Wilbertz; S Horn; H P Nguyen; M Kuhn; S Chanarat; H Wolburg; A Van der Linden; O Riess
Journal:  Neurobiol Dis       Date:  2007-05-18       Impact factor: 5.996

10.  TorsinA binds the KASH domain of nesprins and participates in linkage between nuclear envelope and cytoskeleton.

Authors:  Flávia C Nery; Juan Zeng; Brian P Niland; Jeffrey Hewett; Jonathan Farley; Daniel Irimia; Yuqing Li; Gerhard Wiche; Arnoud Sonnenberg; Xandra O Breakefield
Journal:  J Cell Sci       Date:  2008-09-30       Impact factor: 5.285

View more
  17 in total

Review 1.  Engineering animal models of dystonia.

Authors:  Janneth Oleas; Fumiaki Yokoi; Mark P DeAndrade; Antonio Pisani; Yuqing Li
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

2.  Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice.

Authors:  Fumiaki Yokoi; Janneth Oleas; Hong Xing; Yuning Liu; Kelly M Dexter; Carly Misztal; Melinda Gerard; Iakov Efimenko; Patrick Lynch; Matthew Villanueva; Raul Alsina; Shiv Krishnaswamy; David E Vaillancourt; Yuqing Li
Journal:  Neurobiol Dis       Date:  2019-10-13       Impact factor: 5.996

3.  Electromyographic evidence in support of a knock-in mouse model of DYT1 Dystonia.

Authors:  Mark P DeAndrade; Amy Trongnetrpunya; Fumiaki Yokoi; Chad C Cheetham; Ning Peng; J Michael Wyss; Mingzhou Ding; Yuqing Li
Journal:  Mov Disord       Date:  2016-05-31       Impact factor: 10.338

4.  Improved motor performance in Dyt1 ΔGAG heterozygous knock-in mice by cerebellar Purkinje-cell specific Dyt1 conditional knocking-out.

Authors:  Fumiaki Yokoi; Mai Tu Dang; Yuqing Li
Journal:  Behav Brain Res       Date:  2012-02-25       Impact factor: 3.332

5.  Improved survival and overt "dystonic" symptoms in a torsinA hypofunction mouse model.

Authors:  Fumiaki Yokoi; Fangfang Jiang; Kelly Dexter; Bryan Salvato; Yuqing Li
Journal:  Behav Brain Res       Date:  2019-12-28       Impact factor: 3.332

Review 6.  Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia.

Authors:  K L Eskow Jaunarajs; P Bonsi; M F Chesselet; D G Standaert; A Pisani
Journal:  Prog Neurobiol       Date:  2015-02-17       Impact factor: 11.685

Review 7.  Genetic Aspects of Myoclonus-Dystonia Syndrome (MDS).

Authors:  Laila Rachad; Nadia El Kadmiri; Ilham Slassi; Hicham El Otmani; Sellama Nadifi
Journal:  Mol Neurobiol       Date:  2016-01-20       Impact factor: 5.590

8.  Role of major and brain-specific Sgce isoforms in the pathogenesis of myoclonus-dystonia syndrome.

Authors:  Jianfeng Xiao; Satya R Vemula; Yi Xue; Mohammad M Khan; Francesca A Carlisle; Adrian J Waite; Derek J Blake; Ioannis Dragatsis; Yu Zhao; Mark S LeDoux
Journal:  Neurobiol Dis       Date:  2016-11-24       Impact factor: 5.996

Review 9.  ε-Sarcoglycan: Unraveling the Myoclonus-Dystonia Gene.

Authors:  Ana Cazurro-Gutiérrez; Anna Marcé-Grau; Marta Correa-Vela; Ainara Salazar; María I Vanegas; Alfons Macaya; Àlex Bayés; Belén Pérez-Dueñas
Journal:  Mol Neurobiol       Date:  2021-04-22       Impact factor: 5.590

10.  Recent advances in the molecular pathogenesis of dystonia-plus syndromes and heredodegenerative dystonias.

Authors:  Catharina Casper; Eirini Kalliolia; Thomas T Warner
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.